DOST partners with Sta. Rosa and PGH in medical trials of virgin coconut oil

Published April 28, 2020, 12:00 AM

by manilabulletin_admin

By Dhel Nazario

The first of the three clinical trials of the Virgin Coconut Oil (VCO) of the Department of Science and Technology (DOST) will be participated in by Persons Under Investigation (PUIs) and suspected COVID-19 cases of the Sta. Rosa Community Hospital in Sta. Rosa, Laguna after a collaboration with the local government.

In radio interview with DZBB, Secretary Fortunato dela Pena said that 45 patients will undergo the clinical trial while 45 others will not in order to compare the response of the patients to VCO as a supplement.

“Kami nga ay natutuwa sa collaboration sa pagtanggap sa aming proyekto ni Mayor Arcillas ng Sta. Rosa. Ito po ang unang magsisimula kasi today, Tuesday po nakaschedule ang training nung mga hospital personnel na maiinvolve. (We are happy with the collaboration and for Mayor Arcillas of Sta. Rosa who accepted our project. This will be the first to start because today, Tuesday, is the scheduled training of the hospital personnel who will be involved),” he said.

Meanwhile, the second trial will be at the Philippine General Hospital PGH, 50 patients will take VCO while 50 others will not. The secretary has mentioned that VCO will serve as a supplement to the daily treatment regimen of the COVID-19 positive patients

In PGH, they will assess the possible benefits of VCO if given to patients with moderate to severe COVID-19 in addition to the drugs being assessed in the clinical trials. However, dela Pena shared that there will be a delay in the clinical trial of PGH due to the lack of a ethics board approval.

The DOST is expecting the board approval by May 4.

The third trial will be in Singapore where the study will determine whether certain coconut oil components can diminish or prevent the infectivity of SARS-CoV2, the causative virus of COVID-19.

Herbal medicines are also being looked at by the agency such as Lagundi and Tawa-tawa due to their anti-viral properties.